UA29558C2 - Euphylline h 200, pharmaceutical for treatment of bronchial asthma - Google Patents

Euphylline h 200, pharmaceutical for treatment of bronchial asthma

Info

Publication number
UA29558C2
UA29558C2 UA99127252A UA99127252A UA29558C2 UA 29558 C2 UA29558 C2 UA 29558C2 UA 99127252 A UA99127252 A UA 99127252A UA 99127252 A UA99127252 A UA 99127252A UA 29558 C2 UA29558 C2 UA 29558C2
Authority
UA
Ukraine
Prior art keywords
euphylline
bronchial asthma
pharmaceutical
treatment
theophylline
Prior art date
Application number
UA99127252A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вячеслав Григорович Передерій
Вячеслав Григорьевич Передерий
Юрій Прокопович СПІЖЕНКО
Юрий Прокопьевич Спиженко
Original Assignee
Вячеслав Григорович Передерій
Вячеслав Григорьевич Передерий
Юрій Прокопович СПІЖЕНКО
Спиженко Юрий Прокопович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вячеслав Григорович Передерій, Вячеслав Григорьевич Передерий, Юрій Прокопович СПІЖЕНКО, Спиженко Юрий Прокопович filed Critical Вячеслав Григорович Передерій
Priority to UA99127252A priority Critical patent/UA29558C2/en
Publication of UA29558C2 publication Critical patent/UA29558C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the pharmaceuticals used for the treatment of the bronchial asthma and may be used for arresting the attacks of the bronchial asthma and for treating other bronchopulmonary diseases. The pharmaceutical is based on Theophylline that is freely soluble in water and devoid of the side effects characteristic of Euphylline. At the same time, its efficacy is not inferior to that of Euphylline. The drug may be used for the oral administrations as well as for injections.
UA99127252A 1999-12-30 1999-12-30 Euphylline h 200, pharmaceutical for treatment of bronchial asthma UA29558C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99127252A UA29558C2 (en) 1999-12-30 1999-12-30 Euphylline h 200, pharmaceutical for treatment of bronchial asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99127252A UA29558C2 (en) 1999-12-30 1999-12-30 Euphylline h 200, pharmaceutical for treatment of bronchial asthma

Publications (1)

Publication Number Publication Date
UA29558C2 true UA29558C2 (en) 2000-11-15

Family

ID=74195249

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99127252A UA29558C2 (en) 1999-12-30 1999-12-30 Euphylline h 200, pharmaceutical for treatment of bronchial asthma

Country Status (1)

Country Link
UA (1) UA29558C2 (en)

Similar Documents

Publication Publication Date Title
HUP0003386A2 (en) Use of crf antagonists for the preparation of pharmaceutical compositions treating depression, cardiovascular diseases
MXPA04005790A (en) Compounds and uses thereof for decreasing activity of hormone-sensitive lipase.
EP1426375A3 (en) Analgesic spiroindole derivatives
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
DK1373215T3 (en) Gelanamycin derivatives suitable for the treatment of cancer
NZ515301A (en) Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
WO2002038171A3 (en) METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
HK1076379A1 (en) Use of a composition comprising anti-vla-1 antibody for the preparation of a pharmaceutical composition for the treatment of pulmonary fibrosis
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
RU2005119303A (en) A MODIFIED RELEASE COMPOSITION CONTAINING A CREATIVE SHORT ACTION FOR TREATMENT OF SLEEP DISORDERS
IL151628A0 (en) Combination therapies with vascular damaging activity
CA2392620A1 (en) Use of melatonin for the treatment of androgenetic and diffuse alopecia
SE9603725D0 (en) New teatment
HUP0203682A2 (en) Method for administering a phosphodiesterase 4 inhibitor
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
BR0007452A (en) Use of melagatran or a pharmaceutically acceptable derivative or prodrug thereof, method of treating inflammation, and, pharmaceutical formulation for use in treating inflammation
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
WO2001085188A3 (en) Use of echinacea as a hematinic agent
UA29558C2 (en) Euphylline h 200, pharmaceutical for treatment of bronchial asthma
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
WO2002076400A3 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
MD916G2 (en) Ungent for stomatologic deseases treatment
HK1015708A1 (en) Use of muteins of wild-type cytokines as immunogens.